Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?

by Tomuleasa C, Cucuianu A, Aldea M, Berindan-Neagoe I
Published 2013-10-01

MRI-based identification of undifferentiated cells: looking at the two faces of Janus

by Tomuleasa C, Florian IS, Berce C, Irimie A, Berindan-Neagoe I, Cucuianu A
Published 2014-02-01

Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies

by Kojima S, Cucuianu A, Takahashi Y, Berindan-Neagoe I, Florian IS, Dima D, Tomuleasa C
Published 2014-07-01

Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease

by Tomuleasa C, Petrushev B, Vedean M, Irimie A, Zaharie F, Rosu AM, Dima D, Cucuianu A
Published 2015-03-01

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy

by Petrushev B, Boca S, Simon T, Berce C, Frinc I, Dima D, Selicean S, Gafencu GA, Tanase A, Zdrenghea M, Florea A, Suarasan S, Dima L, Stanciu R, Jurj A, Buzoianu A, Cucuianu A, Astilean S, Irimie A, Tomuleasa C, Berindan-Neagoe I
Published 2016-02-01